Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 8/2022

05-02-2022 | Nitroglycerin | Original Article

MicroPET imaging of bacterial infection with nitroreductase-specific responsive 18F-labelled nitrogen mustard analogues

Authors: Lumei Huang, Jianyang Fang, Shouqiang Hong, Huanhuan Liu, Haotian Zhu, Lixia Feng, Rongqiang Zhuang, Xilin Zhao, Zhide Guo, Xianzhong Zhang

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 8/2022

Login to get access

Abstract

Purpose

Bacterial infection and antibiotic resistance are serious threats to human health. This study aimed to develop two novel radiotracers, 18F-NTRP and 18F-NCRP, that possess a specific nitroreductase (NTR) response to image deep-seated bacterial infections using positron emission tomography (PET). This method can distinguish infection from sterile inflammation.

Methods

18F-NTRP and 18F-NCRP were synthesized via a one-step method; all the steps usually involved in tracer radiosynthesis were successfully adapted in the All-In-One automated module. After the physiochemical properties of 18F-NTRP and 18F-NCRP were characterized, their specificity and selectivity for NTR were verified in E. coli and S. aureus. The ex vivo biodistribution of the tracers was evaluated in normal mice. MicroPET-CT imaging was performed in mouse models of bacterial infection and inflammation after the administration of 18F-NTRP or 18F-NCRP.

Results

Fully automated radiosynthesis of 18F-NTRP and 18F-NCRP was achieved within 90–110 min with overall decay-uncorrected, isolated radiochemical yields of 21.24 ± 4.25% and 11.3 ± 3.78%, respectively. The molar activities of 18F-NTRP and 18F-NCRP were 320 ± 40 GBq/μmol and 275 ± 33 GBq/µmol, respectively. In addition, 18F-NTRP and 18F-NCRP exhibited high selectivity and specificity for NTR response. PET-CT imaging in bacteria-infected mouse models with 18F-NTRP or 18F-NCRP showed significant radioactivity uptake in either E. coli– or S. aureus–infected muscles. The uptake for E. coli–infected muscles, 2.4 ± 0.2%ID/g with 18F-NTRP and 4.05 ± 0.49%ID/g with 18F-NCRP, was up to three times greater than that for uninfected control muscles. Furthermore, for both 18F-NTRP and 18F-NCRP, the uptake in bacterial infection was 2.6 times higher than that in sterile inflammation, allowing an effective distinction of infection from inflammation.

Conclusion

18F-NTRP and 18F-NCRP are worth further investigation to verify their potential clinical application for distinguishing bacterial infection from sterile inflammation via their specific NTR responsiveness.
Appendix
Available only for authorised users
Literature
1.
go back to reference Morens DM, Fauci AS. Emerging infectious diseases: threats to human health and global stability. PLoS Pathog. 2013;9:e1003467. Morens DM, Fauci AS. Emerging infectious diseases: threats to human health and global stability. PLoS Pathog. 2013;9:e1003467.
2.
go back to reference Carlet J, Collignon P, Goldmann D, et al. Society’s failure to protect a precious resource: antibiotics. Lancet. 2011;378:369–71.CrossRef Carlet J, Collignon P, Goldmann D, et al. Society’s failure to protect a precious resource: antibiotics. Lancet. 2011;378:369–71.CrossRef
3.
go back to reference Medina E, Pieper DH. Tackling threats and future problems of multidrug-resistant bacteria. Curr Top Microbiol Immunol. 2016;398:3–33.PubMed Medina E, Pieper DH. Tackling threats and future problems of multidrug-resistant bacteria. Curr Top Microbiol Immunol. 2016;398:3–33.PubMed
4.
go back to reference van Doorn LJ, Henskens Y, Nouhan N, et al. The efficacy of laboratory diagnosis of helicobacter pylori infections in gastric biopsy specimens is related to bacterial density and vacA, cagA, and iceA genotypes. J Clin Microbiol. 2000;38:13–7.CrossRef van Doorn LJ, Henskens Y, Nouhan N, et al. The efficacy of laboratory diagnosis of helicobacter pylori infections in gastric biopsy specimens is related to bacterial density and vacA, cagA, and iceA genotypes. J Clin Microbiol. 2000;38:13–7.CrossRef
5.
go back to reference Li Y, Daryaee F, Yoon GE, et al. Positron emission tomography imaging of Staphylococcus aureus infection using a nitro-prodrug analog of 2-[18F]F-p-aminobenzoic acid. Acs Infect Dis. 2020;6:2249–59.CrossRef Li Y, Daryaee F, Yoon GE, et al. Positron emission tomography imaging of Staphylococcus aureus infection using a nitro-prodrug analog of 2-[18F]F-p-aminobenzoic acid. Acs Infect Dis. 2020;6:2249–59.CrossRef
6.
go back to reference van Osten M, Hahn M, Crane LM, et al. Targeted imaging of bacterial infections: advances, hurdles and hopes. FEMS Microbiol Rev. 2015;39:892–916.CrossRef van Osten M, Hahn M, Crane LM, et al. Targeted imaging of bacterial infections: advances, hurdles and hopes. FEMS Microbiol Rev. 2015;39:892–916.CrossRef
7.
go back to reference Gordon O, Ruiz-Bedoya CA, Ordonez AA, Tucker EW, Jain SK, Molecular imaging: a novel tool to visualize pathogenesis of infections in situ. mBio. 2019;10:e00317–19. Gordon O, Ruiz-Bedoya CA, Ordonez AA, Tucker EW, Jain SK, Molecular imaging: a novel tool to visualize pathogenesis of infections in situ. mBio. 2019;10:e00317–19.
8.
go back to reference James ML, Gambhir SS. A molecular imaging primer: modalities, imaging agents, and applications. Physiol Rev. 2012;92:897–965.CrossRef James ML, Gambhir SS. A molecular imaging primer: modalities, imaging agents, and applications. Physiol Rev. 2012;92:897–965.CrossRef
9.
go back to reference Jain SK. The promise of molecular imaging in the study and treatment of infectious diseases. Mol Imaging Biol. 2017;19:341–7.CrossRef Jain SK. The promise of molecular imaging in the study and treatment of infectious diseases. Mol Imaging Biol. 2017;19:341–7.CrossRef
10.
go back to reference Signore A, Glaudemans AW. The molecular imaging approach to image infections and inflammation by nuclear medicine techniques. Ann Nucl Med. 2011;25:681–700.CrossRef Signore A, Glaudemans AW. The molecular imaging approach to image infections and inflammation by nuclear medicine techniques. Ann Nucl Med. 2011;25:681–700.CrossRef
11.
go back to reference Polvoy I, Flavell RR, Rosenberg OS, Ohliger MA, Wilson DM. Nuclear imaging of bacterial infection: the state of the art and future directions. J Nucl Med. 2020;61:1708–16.CrossRef Polvoy I, Flavell RR, Rosenberg OS, Ohliger MA, Wilson DM. Nuclear imaging of bacterial infection: the state of the art and future directions. J Nucl Med. 2020;61:1708–16.CrossRef
12.
go back to reference Mota F, Ordonez AA, Firth G, et al. Radiotracer development for bacterial imaging. J Med Chem. 2020;63:1964–77.CrossRef Mota F, Ordonez AA, Firth G, et al. Radiotracer development for bacterial imaging. J Med Chem. 2020;63:1964–77.CrossRef
13.
go back to reference Bunschoten A, Welling MM, Termaat MF, Sathekge M, van Leeuwen FW. Development and prospects of dedicated tracers for the molecular imaging of bacterial infections. Bioconjug Chem. 2013;24:1971–89.CrossRef Bunschoten A, Welling MM, Termaat MF, Sathekge M, van Leeuwen FW. Development and prospects of dedicated tracers for the molecular imaging of bacterial infections. Bioconjug Chem. 2013;24:1971–89.CrossRef
14.
go back to reference Weinstein EA, Ordonez AA, Demarco VP, et al. Imaging enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography. Sci Transl Med. 2014;6:259ra146. Weinstein EA, Ordonez AA, Demarco VP, et al. Imaging enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography. Sci Transl Med. 2014;6:259ra146.
15.
go back to reference Yao S, Xing H, Zhu W, et al. Infection imaging with 18F-FDS and first-in-human evaluation. Nucl Med Biol. 2016;43:206–14.CrossRef Yao S, Xing H, Zhu W, et al. Infection imaging with 18F-FDS and first-in-human evaluation. Nucl Med Biol. 2016;43:206–14.CrossRef
16.
go back to reference Ning X, Seo W, Lee S, et al. PET imaging of bacterial infections with fluorine-18-labeled maltohexaose. Angew Chem Int Ed Engl. 2014;53:14096–101.CrossRef Ning X, Seo W, Lee S, et al. PET imaging of bacterial infections with fluorine-18-labeled maltohexaose. Angew Chem Int Ed Engl. 2014;53:14096–101.CrossRef
17.
go back to reference Gowrishankar G, Hardy J, Wardak M, et al. Specific imaging of bacterial infection using 6″-18F-fluoromaltotriose: a second-generation PET tracer targeting the maltodextrin transporter in bacteria. J Nucl Med. 2017;58:1679–84.CrossRef Gowrishankar G, Hardy J, Wardak M, et al. Specific imaging of bacterial infection using 6″-18F-fluoromaltotriose: a second-generation PET tracer targeting the maltodextrin transporter in bacteria. J Nucl Med. 2017;58:1679–84.CrossRef
18.
go back to reference Mutch CA, Ordonez AA, Qin H, et al. [11C]Para-aminobenzoic acid: a positron emission tomography tracer targeting bacteria-specific metabolism. ACS Infect Dis. 2018;4:1067–72.CrossRef Mutch CA, Ordonez AA, Qin H, et al. [11C]Para-aminobenzoic acid: a positron emission tomography tracer targeting bacteria-specific metabolism. ACS Infect Dis. 2018;4:1067–72.CrossRef
19.
go back to reference Zhang Z, Ordonez AA, Wang H, et al. Positron emission tomography imaging with 2-[18F]F-p-aminobenzoic acid detects Staphylococcus aureus infections and monitors drug response. ACS Infect Dis. 2018;4:1635–44.CrossRef Zhang Z, Ordonez AA, Wang H, et al. Positron emission tomography imaging with 2-[18F]F-p-aminobenzoic acid detects Staphylococcus aureus infections and monitors drug response. ACS Infect Dis. 2018;4:1635–44.CrossRef
20.
go back to reference Sellmyer MA, Lee I, Hou C, et al. Bacterial infection imaging with [18F]fluoropropyl-trimethoprim. Proc Natl Acad Sci U S A. 2017;114:8372–7.CrossRef Sellmyer MA, Lee I, Hou C, et al. Bacterial infection imaging with [18F]fluoropropyl-trimethoprim. Proc Natl Acad Sci U S A. 2017;114:8372–7.CrossRef
21.
go back to reference Petrik M, Umlaufova E, Raclavsky V, et al. Imaging of pseudomonas aeruginosa infection with Ga-68 labelled pyoverdine for positron emission tomography. Sci Rep. 2018;8:15698.CrossRef Petrik M, Umlaufova E, Raclavsky V, et al. Imaging of pseudomonas aeruginosa infection with Ga-68 labelled pyoverdine for positron emission tomography. Sci Rep. 2018;8:15698.CrossRef
22.
go back to reference Zhang XM, Zhang HH, Mcleroth P, et al. [124I]FIAU: human dosimetry and infection imaging in patients with suspected prosthetic joint infection. Nucl Med Biol. 2016;43:273–9.CrossRef Zhang XM, Zhang HH, Mcleroth P, et al. [124I]FIAU: human dosimetry and infection imaging in patients with suspected prosthetic joint infection. Nucl Med Biol. 2016;43:273–9.CrossRef
23.
go back to reference Parker MFL, Luu JM, Schulte B, et al. Sensing living bacteria in vivo using D-alanine-derived 11C radiotracers. ACS Cent Sci. 2020;6:155–65.CrossRef Parker MFL, Luu JM, Schulte B, et al. Sensing living bacteria in vivo using D-alanine-derived 11C radiotracers. ACS Cent Sci. 2020;6:155–65.CrossRef
24.
go back to reference Welling MM, Mongera S, Lupetti A, et al. Radiochemical and biological characteristics of 99mTc-UBI 29–41 for imaging of bacterial infections. Nucl Med Biol. 2002;29:413–22.CrossRef Welling MM, Mongera S, Lupetti A, et al. Radiochemical and biological characteristics of 99mTc-UBI 29–41 for imaging of bacterial infections. Nucl Med Biol. 2002;29:413–22.CrossRef
25.
go back to reference Vilche M, Reyes AL, Vasilskis E, et al. Ga-NOTA-UBI-29-41 as a PET tracer for detection of bacterial infection. J Nucl Med. 2016;57:622–7.CrossRef Vilche M, Reyes AL, Vasilskis E, et al. Ga-NOTA-UBI-29-41 as a PET tracer for detection of bacterial infection. J Nucl Med. 2016;57:622–7.CrossRef
26.
go back to reference Li Z, Li X, Gao X, et al. Nitroreductase detection and hypoxic tumor cell imaging by a designed sensitive and selective fluorescent probe, 7-[(5-Nitrofuran-2-yl)methoxy]-3H-phenoxazin-3-one. Anal Chem. 2013;85:3926–32.CrossRef Li Z, Li X, Gao X, et al. Nitroreductase detection and hypoxic tumor cell imaging by a designed sensitive and selective fluorescent probe, 7-[(5-Nitrofuran-2-yl)methoxy]-3H-phenoxazin-3-one. Anal Chem. 2013;85:3926–32.CrossRef
27.
go back to reference Li Y, Sun Y, Li J, et al. Ultrasensitive near-infrared fluorescence-enhanced probe for in vivo nitroreductase imaging. J Am Chem Soc. 2015;137:6407–16.CrossRef Li Y, Sun Y, Li J, et al. Ultrasensitive near-infrared fluorescence-enhanced probe for in vivo nitroreductase imaging. J Am Chem Soc. 2015;137:6407–16.CrossRef
28.
go back to reference Mukherjee A, Rokita SE. Single amino acid switch between a flavin-dependent dehalogenase and nitroreductase. J Am Chem Soc. 2015;137:15342–5.CrossRef Mukherjee A, Rokita SE. Single amino acid switch between a flavin-dependent dehalogenase and nitroreductase. J Am Chem Soc. 2015;137:15342–5.CrossRef
29.
go back to reference Wu X, Shi W, Li X, Ma H. Recognition moieties of small molecular fluorescent probes for bioimaging of enzymes. Acc Chem Res. 2019;52:1892–904.CrossRef Wu X, Shi W, Li X, Ma H. Recognition moieties of small molecular fluorescent probes for bioimaging of enzymes. Acc Chem Res. 2019;52:1892–904.CrossRef
30.
go back to reference Feng P, Zhang H, Deng Q, et al. Real-time bioluminescence imaging of nitroreductase in mouse model. Anal Chem. 2016;88:5610–4.CrossRef Feng P, Zhang H, Deng Q, et al. Real-time bioluminescence imaging of nitroreductase in mouse model. Anal Chem. 2016;88:5610–4.CrossRef
31.
go back to reference Wu LL, Wang Q, Wang Y, et al. Rapid differentiation between bacterial infections and cancer using a near-infrared fluorogenic probe. Chem Sci. 2020;11:3141–5.CrossRef Wu LL, Wang Q, Wang Y, et al. Rapid differentiation between bacterial infections and cancer using a near-infrared fluorogenic probe. Chem Sci. 2020;11:3141–5.CrossRef
32.
go back to reference Qin W, Xu C, Zhao Y, et al. Recent progress in small molecule fluorescent probes for nitroreductase. Chin Chem Lett. 2018;29:1451–5.CrossRef Qin W, Xu C, Zhao Y, et al. Recent progress in small molecule fluorescent probes for nitroreductase. Chin Chem Lett. 2018;29:1451–5.CrossRef
33.
go back to reference Berlanga M, Montero MT, Hernández-Borrell J, Viñas M. Influence of the cell wall on ciprofloxacin susceptibility in selected wild-type Gram-negative and Gram-positive bacteria. Int J Antimicrob Ag. 2004;23:627–30.CrossRef Berlanga M, Montero MT, Hernández-Borrell J, Viñas M. Influence of the cell wall on ciprofloxacin susceptibility in selected wild-type Gram-negative and Gram-positive bacteria. Int J Antimicrob Ag. 2004;23:627–30.CrossRef
34.
go back to reference Mirsepasi-Lauridsen HC, Halkjaer SI, Mortensen EM, et al. Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitis. Sci Rep. 2016;6:31152.CrossRef Mirsepasi-Lauridsen HC, Halkjaer SI, Mortensen EM, et al. Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitis. Sci Rep. 2016;6:31152.CrossRef
35.
go back to reference Anand S, Mandal S, Singh KS, Patil P, Tomar SK. Synbiotic combination of lactobacillus rhamnosus NCDC 298 and short chain fructooligosaccharides prevents enterotoxigenic Escherichia coli infection. LWT Food Sci Technol. 2018;98:329–34.CrossRef Anand S, Mandal S, Singh KS, Patil P, Tomar SK. Synbiotic combination of lactobacillus rhamnosus NCDC 298 and short chain fructooligosaccharides prevents enterotoxigenic Escherichia coli infection. LWT Food Sci Technol. 2018;98:329–34.CrossRef
36.
go back to reference Deng X, Rong J, Wang L, et al. Chemistry for positron emission tomography: recent advances in 11C-, 18F-, 13N- and 15O-labeling reactions. Angew Chem Int Ed Engl. 2019;58:2580–605.CrossRef Deng X, Rong J, Wang L, et al. Chemistry for positron emission tomography: recent advances in 11C-, 18F-, 13N- and 15O-labeling reactions. Angew Chem Int Ed Engl. 2019;58:2580–605.CrossRef
37.
go back to reference Ask K, Décologne N, Asare N, et al. Distribution of nitroreductive activity toward nilutamide in rat. Toxicol Appl Pharmacol. 2004;201:1–9.CrossRef Ask K, Décologne N, Asare N, et al. Distribution of nitroreductive activity toward nilutamide in rat. Toxicol Appl Pharmacol. 2004;201:1–9.CrossRef
Metadata
Title
MicroPET imaging of bacterial infection with nitroreductase-specific responsive 18F-labelled nitrogen mustard analogues
Authors
Lumei Huang
Jianyang Fang
Shouqiang Hong
Huanhuan Liu
Haotian Zhu
Lixia Feng
Rongqiang Zhuang
Xilin Zhao
Zhide Guo
Xianzhong Zhang
Publication date
05-02-2022
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 8/2022
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-022-05710-2

Other articles of this Issue 8/2022

European Journal of Nuclear Medicine and Molecular Imaging 8/2022 Go to the issue